|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 708101-708110 of 2348570 (234857 Page(s) Totally)
<< < 70806 70807 70808 70809 70810 70811 70812 70813 70814 70815 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-08-31T06:29:46Z |
Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
|
ANN-LII CHENG; Thongprasert S.; Lim H.Y.; Sukeepaisarnjaroen W.; Yang T.-S.; Wu C.-C.; Chao Y.; Chan S.L.; Kudo M.; Ikeda M.; Kang Y.-K.; Pan H.; Numata K.; Han G.; Balsara B.; Zhang Y.; Rodriguez A.-M.; Zhang Y.; Wang Y.; Poon R.T.P. |
| 國家衛生研究院 |
2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma
|
Shiah, H;Chen, C;Lin, Y;Su, W;Winkler, R;Chang, J;Lin, P;Whang-Peng, J;Chen, L |
| 國家衛生研究院 |
2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)
|
Chen, L;Shiah, HS;Chen, CY;Lin, YJ;Lin, PW;Su, WC;Chang, JY |
| 國家衛生研究院 |
2018-10 |
Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study
|
Chang, HJ;Chiu, YF;Chen, JS;Li, CP;Ho, CL;Shyr, YM;Chiou, WC;Yeh, CN;Hsieh, RK;Lin, YL;Tien, YW;Hwang, TL;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2015-05 |
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study
|
Chen, LT;Jeng, LB;Hsiao, CF;Wu, CC;Lee, WC;Wang, TE;Lee, PH;Chen, CL;Chen, IS;Lee, KT;Hsieh, CB;Hwang, WS;Yang, MD;Yang, YS;Lin, DY;Chen, MF;Chen, PJ;Taiwan Cooperative Oncology, G |
| 國立臺灣大學 |
2015 |
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study
|
Chen, Li-Tzong; Jeng, Long-Bin; Hsiao, Chin-Fu; Wu, Cheng-Chung; Lee, Wei-Chen; Wang, Tsang-En; Lee, Po-Huang; Chen, Chao-Long; Chen, I-Su; Lee, King-Teh; Hsieh, Chung-Bao; Hwang, Wei-Shou; Yang, Mei-Due; Yang, Yang-Sen; Lin, Deng-Yn; Chen, Miin-Fu; Chen, Pei-Jer; 陳培哲; 李伯皇 |
| 中國醫藥大學 |
2015-03 |
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.
|
(G. V. Scagliotti)*;(I. Bondarenko);(F. Blackhall);(F. Barlesi);夏德椿(Te-Chun Hsia);(J. Jassem);(J. Milanowski);(S. Popat);(J. M. Sanchez-Torres);(S. Novello);(R. J. Benner);(S. Green);(K. Molpus) |
| 國立臺灣大學 |
2002 |
Randomized, Placebo-Controlled Trial of Titrated Intravenous Lamifiban for Acute Coronary Syndromes
|
李源德; LEE, YUAN-THE |
| 國立臺灣大學 |
2009 |
Randomized, Placebo-Controlled, Phase Ii Study of Sequential Erlotinib and Chemotherapy as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer
|
余忠仁; 陳育民; YU, CHONG-JEN; CHEN, YUH-MIN |
| 臺大學術典藏 |
2022-06-27T07:07:47Z |
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
|
Mok T.S.K.; Wu Y.-L.; CHONG-JEN YU; Zhou C.; Chen Y.-M.; Zhang L.; Ignacio J.; Liao M.; Srimuninnimit V.; Boyer M.J.; Chua-Tan M.; Sriuranpong V.; Sudoyo A.W.; Jin K.; Johnston M.; Chui W.; Lee J.-S. |
Showing items 708101-708110 of 2348570 (234857 Page(s) Totally)
<< < 70806 70807 70808 70809 70810 70811 70812 70813 70814 70815 > >>
View [10|25|50] records per page
|
